| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 07/08/1997 | US5646162 Oxy-phenyl-(phenyl)glycinolamides with heterocyclic substituents |
| 07/08/1997 | US5646143 δ-amino-γ-hydroxy-ω-aryl-alkanoic acid amides |
| 07/08/1997 | US5646138 Prevention of inflammatory or allergic reactions, treatment of cardiovascular or haemodynamic disorders |
| 07/08/1997 | US5646136 Methods of inhibiting angiogenesis and tumor growth, and treating ophthalmologic conditions with angiostatic and therapeutic steroids |
| 07/08/1997 | US5646127 Treatment with oligodeoxyribonucleotide |
| 07/08/1997 | US5646042 C-myb targeted ribozymes |
| 07/08/1997 | US5646032 Recombinant foamy virus vectors for medicinal, and diagnostic uses, and processes for preparing recombinant foamy virus vectors |
| 07/08/1997 | CA2057913C N-substituted heterocyclic derivatives, their preparation and the pharmaceutical compositions in which they are present |
| 07/03/1997 | WO1997023783A1 Methods for measurement and treatment predicated on the presence of advanced glycosylation endproducts in tobacco and its combustion byproducts |
| 07/03/1997 | WO1997023625A1 Integrin-linked kinase, its inhibitors and methods of medical treatment using these inhibitors, gene therapy and pseudo-substrate inhibitors |
| 07/03/1997 | WO1997023611A2 Nucleic acid sequences of genes of the high mobility group proteins and uses thereof |
| 07/03/1997 | WO1997023499A1 Prodrugs of thrombin inhibitors |
| 07/03/1997 | WO1997023485A1 Heteroarylcarboxamide derivatives |
| 07/03/1997 | WO1997023482A1 2,7-substituted octahydro-pyrrolo[1,2-a]pyrazine derivatives |
| 07/03/1997 | WO1997023481A1 Trans apovincaminic acid ester derivatives as drugs |
| 07/03/1997 | WO1997023476A1 HETEROCYCLYL-CONDENSED BENZOYLGUANIDINES, THEIR PRODUCTION AND USE AS INHIBITORS OF THE CELLULAR Na+/H+-ANTIPORTER |
| 07/03/1997 | WO1997023462A1 Quinoline and quinazoline compounds useful in therapy |
| 07/03/1997 | WO1997023461A1 Tri-substituted phenyl derivatives useful as pde iv inhibitors |
| 07/03/1997 | WO1997023460A1 Tri-substituted phenyl derivatives useful as pde iv inhibitors |
| 07/03/1997 | WO1997023459A1 Aromatic keto-acids and their derivatives as inhibitors of matrix metalloproteinases |
| 07/03/1997 | WO1997023256A1 Localized intravascular delivery of growth factors for promotion of angiogenesis |
| 07/03/1997 | WO1997023218A1 A process for regulating vagal tone |
| 07/03/1997 | CA2241924A1 Methods for measurement and treatment predicated on the presence of advanced glycosylation endproducts in tobacco and its combustion byproducts |
| 07/03/1997 | CA2241143A1 Heterocyclyl-condensed benzoylguanidines, their production and use as inhibitors of the cellular na+/h+-antiporter |
| 07/03/1997 | CA2239682A1 Nucleic acid sequences of genes of the high mobility group proteins and uses thereof |
| 07/03/1997 | CA2238737A1 Prodrugs of thrombin inhibitors |
| 07/03/1997 | CA2238635A1 Trans apovincaminic acid ester derivatives as drugs |
| 07/02/1997 | EP0781766A1 Heterocyclic derivative and medicine |
| 07/02/1997 | EP0781558A2 Pharmaceutical use of heparin cofactor II |
| 07/02/1997 | EP0781556A1 Use of condensed dihydropyridines for the treatement of chronic inflammatory processes |
| 07/02/1997 | EP0781554A1 Hydroxyl radical scavenger |
| 07/02/1997 | EP0781550A1 Bioadhesive pharmaceutical composition for the controlled release of active agents |
| 07/02/1997 | EP0781334A1 Process for manufacture of a modified collagen-induced platelet aggregation inhibitor pallidipin |
| 07/02/1997 | EP0781295A1 Asp b1 insulin analogs |
| 07/02/1997 | EP0781285A1 Fused indole and quinoxaline derivatives, their preparation and use |
| 07/02/1997 | EP0781284A1 Indole-2,3-dione-3-oxime derivatives, their preparation and use |
| 07/02/1997 | EP0781282A1 [1,2,4]TRIAZOLO[4,3-a]QUINOXALINONE DERIVATIVES, THEIR PREPARATION AND USE |
| 07/02/1997 | EP0781280A1 Derivatives of benzopyran and of benzothiopyran, their preparation and their use as agonists of dopaminergic receptors |
| 07/02/1997 | EP0781278A1 Novel benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake |
| 07/02/1997 | EP0781273A1 4-(4-methanesulfonamidophenyl)butylamine derivatives with antiarrhythmic activity |
| 07/02/1997 | EP0781268A1 Derivatives of 2-amino-1,2,3,4-tetrahydronaphthalene active on the cardiovascular system |
| 07/02/1997 | EP0781126A2 Derivatives of 2-amino-1,2,3,4-tetrahydro-naphthalene active on the cardiovascular system |
| 07/02/1997 | EP0632806B1 Aminocyclohexylamides for antiarrhythmic and anaesthetic uses |
| 07/02/1997 | EP0621871B1 A human kunitz-type protease inhibitor variant |
| 07/02/1997 | CN1153473A Use of droloxifene for treatment of cardiovascular diseases |
| 07/02/1997 | CN1153054A Chinese medicine preparation for reducing fat and dilating coronary artery |
| 07/01/1997 | US5644055 Cyclization of indole or quinoline compound, enzyme inhibitors, treatment of cardiovasacular disorders |
| 07/01/1997 | US5644054 Process for preparing diltiazem |
| 07/01/1997 | US5643964 Natural amino acid derivatives as metalloproteinase inhibitors |
| 07/01/1997 | US5643947 ω-amino-α-phenylalkanonitrile derivatives |
| 07/01/1997 | US5643932 Superoxide radical inhibitor |
| 07/01/1997 | US5643930 6-heterocyclic-4-amino-1,3,4,5,-tetrahydrobenz [cd]indoles |
| 07/01/1997 | US5643925 Benzene derivatives having NGF production-promoting activity |
| 07/01/1997 | US5643921 Cardiopulmonary bypass and organ transplant using a potassium channel activator |
| 07/01/1997 | US5643896 2-Benzyl-3-arylbenzothiophenes |
| 07/01/1997 | US5643879 Oligopeptide enzyme inhibitors as hypotensive agents |
| 07/01/1997 | US5643778 RNA editing enzyme and methods of use thereof |
| 07/01/1997 | CA2134359C New n-aryl and n-heteroarylurea derivatives as inhibitors of acyl coenzyme a: cholesterol acyl transferase (acat) |
| 07/01/1997 | CA2128248C Amino acids useful as inhibitors of the advanced glycosylation of proteins |
| 06/26/1997 | WO1997022880A1 Use of rc-9 in diagnosis and treatment of proliferative arterial disease |
| 06/26/1997 | WO1997022618A1 INHIBITORS OF INTERLEUKIN-1β CONVERTING ENZYME |
| 06/26/1997 | WO1997022596A1 Quinazoline derivatives |
| 06/26/1997 | WO1997022595A1 Arylethenesulfonamide derivatives and drug composition containing the same |
| 06/26/1997 | WO1997022347A1 Potentiation of complement and coagulation inhibitory properties of c1-inhibitor. |
| 06/26/1997 | WO1997022341A1 Endothelin receptor antagonists |
| 06/26/1997 | WO1997022251A1 Compositions for modulating intracellular inositol trisphosphate concentration and uses thereof |
| 06/26/1997 | DE19548708A1 Cyclische Sulfone Cyclic sulfones |
| 06/26/1997 | DE19548122A1 Nukleinsäuresequenzen von Genen der High Mobility Group Proteine sowie Verwendungen derselben Nucleic acid sequences of genes of the high mobility group proteins and uses thereof |
| 06/26/1997 | CA2241004A1 Compositions for modulating intracellular inositol trisphosphate concentration and uses thereof |
| 06/26/1997 | CA2240489A1 Inhibitors of interleukin-1.beta. converting enzyme |
| 06/25/1997 | EP0780398A2 Process for purifying tammhorsfall glycoprotein or uromodulin, their purified products and method for making the discrimination between both of them |
| 06/25/1997 | EP0780388A1 5HT1Dalpha and 5HT2A ligands |
| 06/25/1997 | EP0780124A1 Pharmaceutical composition comprising L-carnitine or an alkanoyl L-carnitine in combination with a polyunsaturated fatty acid of the omega-3 series for the prevention and the treatment of lipid metabolism disorders |
| 06/25/1997 | EP0780123A1 Beta-hydroxybutyric acid or acetoacetic acid or salts or esters therof for use in improving cerebral function |
| 06/25/1997 | EP0779889A1 PYRAZOLO 3,4-g]QUINOXALINE COMPOUNDS WHICH INHIBIT PDGF RECEPTOR PROTEIN TYROSINE KINASE |
| 06/25/1997 | EP0779888A1 Pyrimido [5,4-d]pyrimidines, drugs containing these compounds, their use, and process for preparing them |
| 06/25/1997 | EP0779816A1 Use of insulin-like growth factors (i) and (ii) for inhibition of inflammatory response |
| 06/25/1997 | EP0779811A1 Myocardial protection using benzothiazepinones |
| 06/25/1997 | EP0779810A1 Use of ketoconazole and related substances in medicaments for treatment of type ii diabetes |
| 06/25/1997 | EP0706376B1 Anti-angiogenic compositions and methods of use |
| 06/25/1997 | EP0696199A4 Amidino and guanidino substituted boronic acid inhibitors of trypsin-like enzymes |
| 06/25/1997 | EP0636141B1 Pyrimidinyl acetamides as elastase inhibitors |
| 06/25/1997 | CN1152920A Palladium catalyzed ring closure of triazolyl tryptamine |
| 06/25/1997 | CN1152915A Quinoline derivatives as leukotriene antagonists |
| 06/25/1997 | CN1152871A Methods of use for peroxynitrite decompositionc atalysts, pharmaceutical compositions therefor |
| 06/25/1997 | CN1152869A Treatment for atherosclerosis and other cardiovascular and inflammatory diseases |
| 06/25/1997 | CN1152868A Use of droloxidfene for the treatment of cardiovascular diseases |
| 06/25/1997 | CN1152573A Substituted 2,4-imidazolidinedione compounds as pharmaceutical active ingredients |
| 06/24/1997 | US5641807 Administering 3-amino-5-carbamoylchromans |
| 06/24/1997 | US5641798 Bicyclic compounds and their use as excitatory amino acid receptor antagonists |
| 06/24/1997 | US5641797 6-heterocyclic-4-amino-1,3,4,5-tetrahydrobenz[cd] indoles |
| 06/24/1997 | US5641793 Pyridine compounds which have useful pharmaceutical activity |
| 06/24/1997 | US5641792 Benzoylguanidines substituted by heterocyclic N-oxide, process for their preparation and pharmaceutical compositions containing them |
| 06/24/1997 | US5641789 Sulfonamide derivatives of benzenefused hydroxy substituted cycloalkyl and heterocyclic ring compounds |
| 06/24/1997 | US5641778 Aromatically substituted ω-amino-alkanoic acid amides and alkanoic acid diamides |
| 06/24/1997 | US5641777 Neurokinin receptor antagonist |
| 06/24/1997 | US5641772 Condensed diazepinones, processes for preparing them and agents containing these compounds for treating diseases of the central nervous system and for promoting cerebral blood circulation |
| 06/24/1997 | US5641756 Synthetic oligonucleotide complementary to nucleic acid specific for human vascular endothelial growth factor |
| 06/24/1997 | US5641752 Methods of using endothelin antagonists |
| 06/24/1997 | US5641669 Platelet-activating factor acetylhydrolase |